�������

As a neuropsychiatrist and physician-scientist at ������� Langone, I am dedicated to providing compassionate care to patients and understanding neuropsychiatric conditions through an integrative lens. My work is guided by the principle that optimal treatment and advances in clinical research require a cross-disciplinary approach, one that bridges traditional boundaries between specialties.

I am a board-certified psychiatrist and neurologist and specialize in treating disorders that span brain and behavior. My expertise includes evaluation and treatment of psychiatric symptoms associated with neurologic illness and management of conditions including schizophrenia and mood disorders. My primary research interest is in understanding the role of the immune system in psychiatric illness—particularly in psychosis. In the context of the COVID-19 pandemic, I found that individuals with schizophrenia faced a significantly higher risk of mortality and reduced antibody responses to vaccination. My current research investigates autoantibodies as potential treatment targets in schizophrenia. The ultimate goal of my research and clinical care is to provide mechanism-driven, personalized treatments to patients that improve quality of life.

As part of ������� Langone, I collaborate with a diverse team, ensuring comprehensive and coordinated care for my patients.